Nice
Another 80 million customers
With the opiod statement, this bodes well for USA.
Prost!
Penthrox approved in Germany
Medical Developments International Limited (ASX: MVP) is delighted to announce that Penthrox has been approved for sale in Germany. MVP CEO, Mr. John Sharman said, “We are excited that the Marketing Authorisation for Germany has been received. Germany is one of the most important markets for MVP, as the country is seen by many as a leader in pain drugs and therefore their imprimatur is doubly important for us.
Mr Sharman said: “With a population of almost 83 million people Germany is the largest spender on healthcare in Europe. Germany is also the largest user of opioids in Europe. We anticipate millions of patients could benefit from the introduction of Penthrox as a non-opioid, rapid and safe pain relief treatment.”
- Forums
- ASX - By Stock
- MVP
- Ann: Penthrox approved in Germany
MVP
medical developments international limited
Add to My Watchlist
4.55%
!
46.0¢
Ann: Penthrox approved in Germany, page-4
-
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
